
Sign up to save your podcasts
Or


The ASX200 is eyeing a flat open today with all eyes and ears on the U.S. presidential debate kicking off at 11am AEDT.
The first COVID-19 treatment was approved by the U.S. FDA, giving Gilead Sciences’ drug, Remdesivir, formal approval to treat COVID-19.
What to watch today:
Trading ideas:
By Bell DirectThe ASX200 is eyeing a flat open today with all eyes and ears on the U.S. presidential debate kicking off at 11am AEDT.
The first COVID-19 treatment was approved by the U.S. FDA, giving Gilead Sciences’ drug, Remdesivir, formal approval to treat COVID-19.
What to watch today:
Trading ideas:

16 Listeners

82 Listeners

20 Listeners

8 Listeners

13 Listeners

61 Listeners

21 Listeners

5 Listeners

6 Listeners

1 Listeners

5 Listeners

0 Listeners

4 Listeners

1 Listeners

0 Listeners